Clinical efficacy on treatment of macrolide-unresponsiv mycoplasma pneumoniae pneumonia with Xiao Qinglong and Xiao Chaihu Modifications Decoction
Objective:To explore the clinical efficacy of Xiao Qinglong and Xiao Chaihu Modifications Decoction in the treatment of children with macrolide-unresponsiv mycoplasma pneumoniae pneumonia(MUMPP).Methods:A total of 80 children with MUMPP in Shijingshan Teaching Hospital,Capital Medical University,Beijing Shijingshan Hospital from February to December,2023 were randomly divided into Chinese medicine group and Western medicine group,40 children in each group.The Chinese medicine group was given Xiao Qinglong and Xiao Chaihu Modifications Decoction,while the Western medicine group was given anti-infection and symptomatic treatment of Azithromycin.Before and after treatment,the traditional Chinese medicine(TCM)syndrome scores and the changes of inflammatory lesions on chest CT were observed and compared between the two groups.Results:After treatment,the TCM syndrome score of the Chinese medicine group was significantly better than that of the Western medicine group(P＜0.05).The effective rate was 87.5％(35/40)in the Chinese medicine group,it was batter than that in the Western medicine group[47.5％(19/40)](P＜0.01).The conversion rate of imaging in the Chinese medicine group[82.5％(33/40)]was significantly better than that in the Western medicine group[50.0％(20/40)](P＜0.05),and there were no adverse reactions.Conclusion:Xiao Qinglong and Xiao Chaihu Modifications Decoction are effective in the treatment of MUMPPP and worth popularizing.
NETL
NSTL
万方数据
